nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—NR3C1—urine—kidney cancer	0.0118	0.174	CbGeAlD
Fluocinolone Acetonide—SERPINA6—nephron tubule—kidney cancer	0.00726	0.107	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—renal system—kidney cancer	0.00663	0.0976	CbGeAlD
Fluocinolone Acetonide—SERPINA6—renal system—kidney cancer	0.0066	0.0972	CbGeAlD
Fluocinolone Acetonide—SERPINA6—kidney—kidney cancer	0.00638	0.094	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—cortex of kidney—kidney cancer	0.00624	0.0919	CbGeAlD
Fluocinolone Acetonide—SERPINA6—cortex of kidney—kidney cancer	0.00621	0.0915	CbGeAlD
Fluocinolone Acetonide—Amcinonide—ANXA1—kidney cancer	0.00579	0.431	CrCbGaD
Fluocinolone Acetonide—NR3C1—nephron tubule—kidney cancer	0.00318	0.0468	CbGeAlD
Fluocinolone Acetonide—NR3C1—renal system—kidney cancer	0.00289	0.0426	CbGeAlD
Fluocinolone Acetonide—NR3C1—kidney—kidney cancer	0.00279	0.0412	CbGeAlD
Fluocinolone Acetonide—NR3C1—cortex of kidney—kidney cancer	0.00272	0.0401	CbGeAlD
Fluocinolone Acetonide—NR3C1—gonad—kidney cancer	0.00259	0.0382	CbGeAlD
Fluocinolone Acetonide—NR3C1—cardiac atrium—kidney cancer	0.00259	0.0381	CbGeAlD
Fluocinolone Acetonide—Dexamethasone—ANXA1—kidney cancer	0.00182	0.135	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—BCHE—kidney cancer	0.00111	0.0829	CrCbGaD
Fluocinolone Acetonide—Clobetasol propionate—CYP1A1—kidney cancer	0.00105	0.0778	CrCbGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—JUNB—kidney cancer	0.00103	0.00551	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—ACHE—kidney cancer	0.00102	0.00548	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—JUN—kidney cancer	0.000992	0.00532	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—HIF1A—kidney cancer	0.00099	0.00531	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—EGR1—kidney cancer	0.00096	0.00515	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000955	0.00513	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000955	0.00513	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—kidney cancer	0.000945	0.00507	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PAK1—kidney cancer	0.000913	0.0049	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGF Pathway—JUN—kidney cancer	0.000909	0.00488	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000906	0.00486	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—kidney cancer	0.000899	0.00482	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—BCHE—kidney cancer	0.00089	0.00478	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Ca-dependent events—MAPK1—kidney cancer	0.000882	0.00473	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—EGR1—kidney cancer	0.000846	0.00454	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000827	0.00444	CbGpPWpGaD
Fluocinolone Acetonide—Viral infection—Doxorubicin—kidney cancer	0.000818	0.00112	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Temsirolimus—kidney cancer	0.000817	0.00112	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—p38 MAPK Signaling Pathway—MYC—kidney cancer	0.000816	0.00438	CbGpPWpGaD
Fluocinolone Acetonide—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000814	0.00111	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Circadian Clock—HIF1A—kidney cancer	0.00081	0.00435	CbGpPWpGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000809	0.0011	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Sorafenib—kidney cancer	0.000804	0.0011	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Doxorubicin—kidney cancer	0.000801	0.00109	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Doxorubicin—kidney cancer	0.000801	0.00109	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Vincristine—kidney cancer	0.000796	0.00109	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Pazopanib—kidney cancer	0.000795	0.00109	CcSEcCtD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.000795	0.00426	CbGpPWpGaD
Fluocinolone Acetonide—Cough—Sunitinib—kidney cancer	0.000793	0.00108	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Temsirolimus—kidney cancer	0.000789	0.00108	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000788	0.00423	CbGpPWpGaD
Fluocinolone Acetonide—Infestation NOS—Paclitaxel—kidney cancer	0.000781	0.00107	CcSEcCtD
Fluocinolone Acetonide—Infestation—Paclitaxel—kidney cancer	0.000781	0.00107	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00078	0.00107	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Vincristine—kidney cancer	0.00078	0.00107	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—L1CAM—kidney cancer	0.000778	0.00417	CbGpPWpGaD
Fluocinolone Acetonide—Arthralgia—Sunitinib—kidney cancer	0.000774	0.00106	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Vincristine—kidney cancer	0.000773	0.00106	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Pazopanib—kidney cancer	0.000769	0.00105	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	0.000769	0.00412	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Everolimus—kidney cancer	0.000766	0.00105	CcSEcCtD
Fluocinolone Acetonide—Infection—Sorafenib—kidney cancer	0.000766	0.00105	CcSEcCtD
Fluocinolone Acetonide—Pain—Vinblastine—kidney cancer	0.000762	0.00104	CcSEcCtD
Fluocinolone Acetonide—Pain—Everolimus—kidney cancer	0.000759	0.00104	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Temsirolimus—kidney cancer	0.000759	0.00104	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Sorafenib—kidney cancer	0.000756	0.00103	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Gemcitabine—kidney cancer	0.000755	0.00103	CcSEcCtD
Fluocinolone Acetonide—Rash—Temsirolimus—kidney cancer	0.000753	0.00103	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Temsirolimus—kidney cancer	0.000752	0.00103	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGF Pathway—MAPK3—kidney cancer	0.000751	0.00403	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Temsirolimus—kidney cancer	0.000748	0.00102	CcSEcCtD
Fluocinolone Acetonide—Neck pain—Doxorubicin—kidney cancer	0.000748	0.00102	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Capecitabine—kidney cancer	0.000744	0.00102	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	0.000744	0.00399	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Pazopanib—kidney cancer	0.000744	0.00102	CcSEcCtD
Fluocinolone Acetonide—Back pain—Vincristine—kidney cancer	0.000743	0.00102	CcSEcCtD
Fluocinolone Acetonide—Oedema—Sunitinib—kidney cancer	0.000742	0.00101	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Gemcitabine—kidney cancer	0.00074	0.00101	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00074	0.00101	CcSEcCtD
Fluocinolone Acetonide—Infection—Sunitinib—kidney cancer	0.000737	0.00101	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Paclitaxel—kidney cancer	0.000733	0.001	CcSEcCtD
Fluocinolone Acetonide—Pain—Erlotinib—kidney cancer	0.000733	0.001	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Doxorubicin—kidney cancer	0.00073	0.000997	CcSEcCtD
Fluocinolone Acetonide—Erythema—Gemcitabine—kidney cancer	0.000729	0.000996	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RAF1—kidney cancer	0.000729	0.00391	CbGpPWpGaD
Fluocinolone Acetonide—Nervous system disorder—Sunitinib—kidney cancer	0.000727	0.000993	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RELA—kidney cancer	0.000726	0.00389	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000724	0.00388	CbGpPWpGaD
Fluocinolone Acetonide—Influenza—Capecitabine—kidney cancer	0.000719	0.000982	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGF Pathway—MAPK1—kidney cancer	0.000715	0.00384	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Pazopanib—kidney cancer	0.000715	0.000976	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Endothelins—RAF1—kidney cancer	0.00071	0.00381	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Pazopanib—kidney cancer	0.000709	0.000968	CcSEcCtD
Fluocinolone Acetonide—Nausea—Temsirolimus—kidney cancer	0.000709	0.000968	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000708	0.0038	CbGpPWpGaD
Fluocinolone Acetonide—Dermatitis—Pazopanib—kidney cancer	0.000708	0.000967	CcSEcCtD
Fluocinolone Acetonide—Back pain—Gemcitabine—kidney cancer	0.000705	0.000963	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Opioid Signalling—POMC—kidney cancer	0.000705	0.00378	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Pazopanib—kidney cancer	0.000704	0.000962	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Paclitaxel—kidney cancer	0.000703	0.00096	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000702	0.000959	CcSEcCtD
Fluocinolone Acetonide—Oedema—Dactinomycin—kidney cancer	0.000702	0.000959	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Everolimus—kidney cancer	0.000702	0.000958	CcSEcCtD
Fluocinolone Acetonide—Infection—Dactinomycin—kidney cancer	0.000697	0.000952	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Vincristine—kidney cancer	0.00069	0.000943	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Paclitaxel—kidney cancer	0.000689	0.000941	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—RAF1—kidney cancer	0.000684	0.00367	CbGpPWpGaD
Fluocinolone Acetonide—Dry eye—Doxorubicin—kidney cancer	0.000682	0.000932	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—RELA—kidney cancer	0.000681	0.00366	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Erlotinib—kidney cancer	0.000677	0.000925	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Paclitaxel—kidney cancer	0.000676	0.000923	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000676	0.000923	CcSEcCtD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—HIF1A—kidney cancer	0.000668	0.00358	CbGpPWpGaD
Fluocinolone Acetonide—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000668	0.000912	CcSEcCtD
Fluocinolone Acetonide—Nausea—Pazopanib—kidney cancer	0.000668	0.000912	CcSEcCtD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000667	0.00358	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000665	0.000909	CcSEcCtD
Fluocinolone Acetonide—Pain—Sorafenib—kidney cancer	0.000659	0.0009	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Vinblastine—kidney cancer	0.000657	0.000897	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Paclitaxel—kidney cancer	0.000655	0.000895	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—kidney cancer	0.000655	0.00351	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Everolimus—kidney cancer	0.000654	0.000893	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.00065	0.00349	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.00065	0.00349	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PLC beta mediated events—MAPK1—kidney cancer	0.000649	0.00348	CbGpPWpGaD
Fluocinolone Acetonide—Fluticasone furoate—ABCB1—kidney cancer	0.000649	0.0483	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—OR4C13—kidney cancer	0.000644	0.00346	CbGpPWpGaD
Fluocinolone Acetonide—Infestation—Capecitabine—kidney cancer	0.000641	0.000875	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Capecitabine—kidney cancer	0.000641	0.000875	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00064	0.000874	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00064	0.000873	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—G-protein mediated events—MAPK1—kidney cancer	0.000638	0.00342	CbGpPWpGaD
Fluocinolone Acetonide—Cough—Gemcitabine—kidney cancer	0.000636	0.000869	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—JUN—kidney cancer	0.000636	0.00341	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Sunitinib—kidney cancer	0.000634	0.000866	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Paclitaxel—kidney cancer	0.000632	0.000863	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Everolimus—kidney cancer	0.000628	0.000858	CcSEcCtD
Fluocinolone Acetonide—Oedema—Vincristine—kidney cancer	0.000627	0.000857	CcSEcCtD
Fluocinolone Acetonide—Infection—Vincristine—kidney cancer	0.000623	0.000851	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Gemcitabine—kidney cancer	0.000621	0.000848	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Paclitaxel—kidney cancer	0.00062	0.000846	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Endothelins—JUN—kidney cancer	0.00062	0.00332	CbGpPWpGaD
Fluocinolone Acetonide—Nervous system disorder—Vincristine—kidney cancer	0.000615	0.00084	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Paclitaxel—kidney cancer	0.000614	0.000839	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Paclitaxel—kidney cancer	0.00061	0.000834	CcSEcCtD
Fluocinolone Acetonide—Erythema—Paclitaxel—kidney cancer	0.00061	0.000834	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Vinblastine—kidney cancer	0.00061	0.000833	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Sorafenib—kidney cancer	0.000609	0.000832	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000608	0.00326	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Everolimus—kidney cancer	0.000607	0.00083	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Erlotinib—kidney cancer	0.000606	0.000828	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—APC—kidney cancer	0.000602	0.00323	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Dactinomycin—kidney cancer	0.0006	0.00082	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Paclitaxel—kidney cancer	0.000598	0.000816	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—JUN—kidney cancer	0.000597	0.0032	CbGpPWpGaD
Fluocinolone Acetonide—Eczema—Doxorubicin—kidney cancer	0.000597	0.000815	CcSEcCtD
Fluocinolone Acetonide—Oedema—Gemcitabine—kidney cancer	0.000595	0.000813	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Doxorubicin—kidney cancer	0.000594	0.000811	CcSEcCtD
Fluocinolone Acetonide—Infection—Gemcitabine—kidney cancer	0.000591	0.000807	CcSEcCtD
Fluocinolone Acetonide—Back pain—Paclitaxel—kidney cancer	0.00059	0.000806	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ANXA2—kidney cancer	0.00059	0.00316	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Vinblastine—kidney cancer	0.000589	0.000805	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Everolimus—kidney cancer	0.000587	0.000802	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Sunitinib—kidney cancer	0.000586	0.000801	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Erlotinib—kidney cancer	0.000586	0.0008	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Gemcitabine—kidney cancer	0.000583	0.000797	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Capecitabine—kidney cancer	0.000577	0.000788	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Paclitaxel—kidney cancer	0.000575	0.000786	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000571	0.00078	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Sorafenib—kidney cancer	0.000568	0.000775	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Vinblastine—kidney cancer	0.000567	0.000774	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Erlotinib—kidney cancer	0.000566	0.000774	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Capecitabine—kidney cancer	0.000565	0.000772	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Everolimus—kidney cancer	0.000564	0.000771	CcSEcCtD
Fluocinolone Acetonide—Rash—Everolimus—kidney cancer	0.00056	0.000764	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Everolimus—kidney cancer	0.000559	0.000764	CcSEcCtD
Fluocinolone Acetonide—Headache—Vinblastine—kidney cancer	0.000558	0.000762	CcSEcCtD
Fluocinolone Acetonide—Headache—Everolimus—kidney cancer	0.000556	0.00076	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Dactinomycin—kidney cancer	0.000555	0.000758	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Capecitabine—kidney cancer	0.000555	0.000757	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Doxorubicin—kidney cancer	0.000549	0.00075	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Paclitaxel—kidney cancer	0.000548	0.000749	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Sunitinib—kidney cancer	0.000546	0.000746	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Sorafenib—kidney cancer	0.000545	0.000745	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Erlotinib—kidney cancer	0.000545	0.000744	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000542	0.00074	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000541	0.000739	CcSEcCtD
Fluocinolone Acetonide—Rash—Erlotinib—kidney cancer	0.00054	0.000738	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Erlotinib—kidney cancer	0.00054	0.000737	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Capecitabine—kidney cancer	0.000538	0.000734	CcSEcCtD
Fluocinolone Acetonide—Headache—Erlotinib—kidney cancer	0.000537	0.000733	CcSEcCtD
Fluocinolone Acetonide—Pain—Vincristine—kidney cancer	0.000536	0.000732	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Doxorubicin—kidney cancer	0.000536	0.000732	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Doxorubicin—kidney cancer	0.000536	0.000732	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000534	0.00286	CbGpPWpGaD
Fluocinolone Acetonide—Cough—Paclitaxel—kidney cancer	0.000533	0.000727	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vinblastine—kidney cancer	0.000529	0.000723	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000529	0.00284	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Everolimus—kidney cancer	0.000527	0.00072	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Sorafenib—kidney cancer	0.000527	0.00072	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK3—kidney cancer	0.000525	0.00282	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Sunitinib—kidney cancer	0.000525	0.000716	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Paclitaxel—kidney cancer	0.00052	0.00071	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Capecitabine—kidney cancer	0.000519	0.000708	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—ABCB1—kidney cancer	0.000517	0.0385	CrCbGaD
Fluocinolone Acetonide—Hypersensitivity—Dactinomycin—kidney cancer	0.000517	0.000706	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000517	0.00277	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000514	0.000702	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—PTGS2—kidney cancer	0.000513	0.0382	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—MAPK3—kidney cancer	0.000512	0.00275	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Sorafenib—kidney cancer	0.00051	0.000696	CcSEcCtD
Fluocinolone Acetonide—Pain—Gemcitabine—kidney cancer	0.000509	0.000695	CcSEcCtD
Fluocinolone Acetonide—Nausea—Erlotinib—kidney cancer	0.000509	0.000695	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Capecitabine—kidney cancer	0.000508	0.000694	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Sunitinib—kidney cancer	0.000507	0.000693	CcSEcCtD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000506	0.00271	CbGpPWpGaD
Fluocinolone Acetonide—Mental disorder—Capecitabine—kidney cancer	0.000504	0.000688	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Regulation of Androgen receptor activity—JUN—kidney cancer	0.000503	0.0027	CbGpPWpGaD
Fluocinolone Acetonide—Malnutrition—Capecitabine—kidney cancer	0.000501	0.000684	CcSEcCtD
Fluocinolone Acetonide—Erythema—Capecitabine—kidney cancer	0.000501	0.000684	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK1—kidney cancer	0.0005	0.00268	CbGpPWpGaD
Fluocinolone Acetonide—Oedema—Paclitaxel—kidney cancer	0.000498	0.00068	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Vincristine—kidney cancer	0.000496	0.000677	CcSEcCtD
Fluocinolone Acetonide—Infection—Paclitaxel—kidney cancer	0.000495	0.000676	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—kidney cancer	0.000494	0.00265	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—MAPK3—kidney cancer	0.000493	0.00265	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—BRAF—kidney cancer	0.000492	0.00264	CbGpPWpGaD
Fluocinolone Acetonide—Dysgeusia—Capecitabine—kidney cancer	0.000491	0.00067	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Sunitinib—kidney cancer	0.00049	0.00067	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Sorafenib—kidney cancer	0.00049	0.000669	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KCNMA1—kidney cancer	0.000489	0.00262	CbGpPWpGaD
Fluocinolone Acetonide—Nervous system disorder—Paclitaxel—kidney cancer	0.000489	0.000667	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Endothelins—MAPK1—kidney cancer	0.000487	0.00261	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Sorafenib—kidney cancer	0.000486	0.000664	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Sorafenib—kidney cancer	0.000485	0.000663	CcSEcCtD
Fluocinolone Acetonide—Back pain—Capecitabine—kidney cancer	0.000485	0.000662	CcSEcCtD
Fluocinolone Acetonide—Headache—Sorafenib—kidney cancer	0.000483	0.000659	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Dactinomycin—kidney cancer	0.00048	0.000656	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Doxorubicin—kidney cancer	0.000479	0.000655	CcSEcCtD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CDKN2A—kidney cancer	0.000478	0.00256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IGF2—kidney cancer	0.000473	0.00254	CbGpPWpGaD
Fluocinolone Acetonide—Vision blurred—Capecitabine—kidney cancer	0.000472	0.000645	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Sunitinib—kidney cancer	0.000471	0.000644	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Gemcitabine—kidney cancer	0.00047	0.000642	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—MAPK1—kidney cancer	0.000469	0.00252	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Sunitinib—kidney cancer	0.000468	0.000639	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Sunitinib—kidney cancer	0.000467	0.000638	CcSEcCtD
Fluocinolone Acetonide—Headache—Sunitinib—kidney cancer	0.000465	0.000634	CcSEcCtD
Fluocinolone Acetonide—Influenza—Doxorubicin—kidney cancer	0.000463	0.000633	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Vincristine—kidney cancer	0.000462	0.000631	CcSEcCtD
Fluocinolone Acetonide—Nausea—Sorafenib—kidney cancer	0.000458	0.000625	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ACY1—kidney cancer	0.000455	0.00244	CbGpPWpGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000454	0.00062	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Capecitabine—kidney cancer	0.00045	0.000615	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Dactinomycin—kidney cancer	0.000446	0.00061	CcSEcCtD
Fluocinolone Acetonide—Rash—Dactinomycin—kidney cancer	0.000443	0.000604	CcSEcCtD
Fluocinolone Acetonide—Nausea—Sunitinib—kidney cancer	0.00044	0.000602	CcSEcCtD
Fluocinolone Acetonide—Cough—Capecitabine—kidney cancer	0.000437	0.000597	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PIK3CA—kidney cancer	0.000434	0.00233	CbGpPWpGaD
Fluocinolone Acetonide—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000431	0.000588	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00043	0.000587	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Vincristine—kidney cancer	0.000429	0.000586	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Capecitabine—kidney cancer	0.000426	0.000582	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—GRB7—kidney cancer	0.000426	0.00229	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Paclitaxel—kidney cancer	0.000426	0.000582	CcSEcCtD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CDKN1B—kidney cancer	0.000423	0.00227	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Gemcitabine—kidney cancer	0.000421	0.000575	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—PTGS2—kidney cancer	0.00042	0.0313	CrCbGaD
Fluocinolone Acetonide—Nausea—Dactinomycin—kidney cancer	0.000417	0.000569	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Vincristine—kidney cancer	0.000415	0.000566	CcSEcCtD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL2—kidney cancer	0.000414	0.00222	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HARS—kidney cancer	0.000414	0.00222	CbGpPWpGaD
Fluocinolone Acetonide—Infestation NOS—Doxorubicin—kidney cancer	0.000413	0.000564	CcSEcCtD
Fluocinolone Acetonide—Infestation—Doxorubicin—kidney cancer	0.000413	0.000564	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—RAF1—kidney cancer	0.000411	0.0022	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—CTNNB1—kidney cancer	0.000409	0.0022	CbGpPWpGaD
Fluocinolone Acetonide—Oedema—Capecitabine—kidney cancer	0.000409	0.000558	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Adipogenesis—HIF1A—kidney cancer	0.000407	0.00218	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Gemcitabine—kidney cancer	0.000407	0.000556	CcSEcCtD
Fluocinolone Acetonide—Infection—Capecitabine—kidney cancer	0.000406	0.000555	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—kidney cancer	0.000405	0.00217	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CCND1—kidney cancer	0.000404	0.00217	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—JUN—kidney cancer	0.000403	0.00216	CbGpPWpGaD
Fluocinolone Acetonide—Nervous system disorder—Capecitabine—kidney cancer	0.000401	0.000547	CcSEcCtD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CTNNB1—kidney cancer	0.0004	0.00215	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Vincristine—kidney cancer	0.000399	0.000545	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Opioid Signalling—MAPK1—kidney cancer	0.000398	0.00214	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ITPR2—kidney cancer	0.000396	0.00213	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Vincristine—kidney cancer	0.000395	0.00054	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Vincristine—kidney cancer	0.000395	0.00054	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Paclitaxel—kidney cancer	0.000394	0.000538	CcSEcCtD
Fluocinolone Acetonide—Headache—Vincristine—kidney cancer	0.000393	0.000537	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP1A1—kidney cancer	0.000391	0.0291	CrCbGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—PTEN—kidney cancer	0.00039	0.00209	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000388	0.00208	CbGpPWpGaD
Fluocinolone Acetonide—Sinusitis—Doxorubicin—kidney cancer	0.000388	0.000529	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PDHB—kidney cancer	0.000387	0.00208	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—OR4C13—kidney cancer	0.000381	0.00204	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Gemcitabine—kidney cancer	0.000378	0.000517	CcSEcCtD
Fluocinolone Acetonide—Rash—Gemcitabine—kidney cancer	0.000375	0.000512	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Gemcitabine—kidney cancer	0.000375	0.000512	CcSEcCtD
Fluocinolone Acetonide—Headache—Gemcitabine—kidney cancer	0.000373	0.000509	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000373	0.002	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Vincristine—kidney cancer	0.000373	0.000509	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000372	0.000509	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Doxorubicin—kidney cancer	0.000372	0.000508	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Paclitaxel—kidney cancer	0.000367	0.000501	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—kidney cancer	0.000365	0.00196	CbGpPWpGaD
Fluocinolone Acetonide—Prednisolone—ABCB1—kidney cancer	0.000365	0.0272	CrCbGaD
Fluocinolone Acetonide—Connective tissue disorder—Doxorubicin—kidney cancer	0.000364	0.000498	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CCBL1—kidney cancer	0.000364	0.00195	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000359	0.00192	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—JUN—kidney cancer	0.000358	0.00192	CbGpPWpGaD
Fluocinolone Acetonide—Visual impairment—Doxorubicin—kidney cancer	0.000357	0.000488	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—ABCB1—kidney cancer	0.000357	0.0266	CrCbGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—kidney cancer	0.000355	0.0019	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Gemcitabine—kidney cancer	0.000353	0.000483	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000353	0.000482	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Paclitaxel—kidney cancer	0.000352	0.000481	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Gene Expression—EIF5B—kidney cancer	0.000352	0.00189	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000352	0.00189	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Capecitabine—kidney cancer	0.00035	0.000477	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Doxorubicin—kidney cancer	0.000347	0.000473	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PTEN—kidney cancer	0.000346	0.00186	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Paclitaxel—kidney cancer	0.000341	0.000465	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Doxorubicin—kidney cancer	0.000334	0.000457	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Paclitaxel—kidney cancer	0.000329	0.00045	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000329	0.00177	CbGpPWpGaD
Fluocinolone Acetonide—Alopecia—Doxorubicin—kidney cancer	0.000328	0.000448	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Doxorubicin—kidney cancer	0.000325	0.000444	CcSEcCtD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	0.000324	0.00174	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LATS1—kidney cancer	0.000324	0.00174	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Capecitabine—kidney cancer	0.000323	0.000441	CcSEcCtD
Fluocinolone Acetonide—Erythema—Doxorubicin—kidney cancer	0.000323	0.000441	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Doxorubicin—kidney cancer	0.000323	0.000441	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PTEN—kidney cancer	0.00032	0.00172	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Paclitaxel—kidney cancer	0.000317	0.000433	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Doxorubicin—kidney cancer	0.000316	0.000432	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GLIPR1—kidney cancer	0.000315	0.00169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPAT—kidney cancer	0.000315	0.00169	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Paclitaxel—kidney cancer	0.000314	0.000429	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Paclitaxel—kidney cancer	0.000314	0.000429	CcSEcCtD
Fluocinolone Acetonide—Back pain—Doxorubicin—kidney cancer	0.000312	0.000427	CcSEcCtD
Fluocinolone Acetonide—Headache—Paclitaxel—kidney cancer	0.000312	0.000426	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000311	0.00167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000308	0.00165	CbGpPWpGaD
Fluocinolone Acetonide—Vision blurred—Doxorubicin—kidney cancer	0.000304	0.000416	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Capecitabine—kidney cancer	0.000301	0.000411	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MAPK3—kidney cancer	0.000296	0.00159	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Paclitaxel—kidney cancer	0.000296	0.000404	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	0.000293	0.00157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APRT—kidney cancer	0.000293	0.00157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—FH—kidney cancer	0.000293	0.00157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000292	0.00157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IFNA1—kidney cancer	0.000291	0.00156	CbGpPWpGaD
Fluocinolone Acetonide—Vertigo—Doxorubicin—kidney cancer	0.00029	0.000396	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000289	0.00155	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Capecitabine—kidney cancer	0.000289	0.000395	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000288	0.00155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MYC—kidney cancer	0.000288	0.00154	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000287	0.00154	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000283	0.00152	CbGpPWpGaD
Fluocinolone Acetonide—Cough—Doxorubicin—kidney cancer	0.000282	0.000385	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MAPK1—kidney cancer	0.000282	0.00151	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Capecitabine—kidney cancer	0.00028	0.000382	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	0.000279	0.0015	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GPC3—kidney cancer	0.000276	0.00148	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AMER1—kidney cancer	0.000275	0.00148	CbGpPWpGaD
Fluocinolone Acetonide—Arthralgia—Doxorubicin—kidney cancer	0.000275	0.000375	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IFNA2—kidney cancer	0.000271	0.00145	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Capecitabine—kidney cancer	0.00027	0.000369	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CA2—kidney cancer	0.000268	0.00144	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000268	0.00144	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKAP13—kidney cancer	0.000267	0.00144	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	0.000266	0.00143	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—KRAS—kidney cancer	0.000266	0.00143	CbGpPWpGaD
Fluocinolone Acetonide—Oedema—Doxorubicin—kidney cancer	0.000264	0.00036	CcSEcCtD
Fluocinolone Acetonide—Infection—Doxorubicin—kidney cancer	0.000262	0.000358	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALAD—kidney cancer	0.000261	0.0014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—RAF1—kidney cancer	0.00026	0.0014	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Capecitabine—kidney cancer	0.00026	0.000355	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Doxorubicin—kidney cancer	0.000258	0.000353	CcSEcCtD
Fluocinolone Acetonide—Rash—Capecitabine—kidney cancer	0.000258	0.000352	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Capecitabine—kidney cancer	0.000258	0.000352	CcSEcCtD
Fluocinolone Acetonide—Headache—Capecitabine—kidney cancer	0.000256	0.00035	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000256	0.00137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ST3GAL2—kidney cancer	0.000255	0.00137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000255	0.00137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000253	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALDH1A1—kidney cancer	0.000249	0.00134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000247	0.00132	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—kidney cancer	0.000244	0.0182	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—kidney cancer	0.000244	0.00131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF2—kidney cancer	0.000244	0.00131	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—CTNNB1—kidney cancer	0.000244	0.00131	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Capecitabine—kidney cancer	0.000243	0.000332	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.00024	0.000328	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PGK1—kidney cancer	0.000239	0.00128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC5A3—kidney cancer	0.000239	0.00128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LDHB—kidney cancer	0.000234	0.00126	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	0.000234	0.00126	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IL2—kidney cancer	0.000233	0.00125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GPC3—kidney cancer	0.000231	0.00124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CER1—kidney cancer	0.000231	0.00124	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	0.000228	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000228	0.000311	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ITPR2—kidney cancer	0.000227	0.00122	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EEF2—kidney cancer	0.000227	0.00122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3CA—kidney cancer	0.000226	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Doxorubicin—kidney cancer	0.000225	0.000308	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000223	0.0012	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—TET2—kidney cancer	0.000218	0.00117	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000212	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000211	0.00113	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000211	0.00113	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Doxorubicin—kidney cancer	0.000208	0.000284	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—ABCB1—kidney cancer	0.000208	0.0155	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000205	0.0011	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CA9—kidney cancer	0.000203	0.00109	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000201	0.00108	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—TCEB1—kidney cancer	0.000199	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—TCEB2—kidney cancer	0.000199	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000199	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	0.000198	0.00106	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SFRP2—kidney cancer	0.000196	0.00105	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Doxorubicin—kidney cancer	0.000194	0.000265	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ANXA1—kidney cancer	0.000191	0.00102	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000189	0.00102	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	0.000188	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Doxorubicin—kidney cancer	0.000186	0.000255	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000186	0.000998	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000185	0.000995	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Doxorubicin—kidney cancer	0.00018	0.000246	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	0.000179	0.000958	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Doxorubicin—kidney cancer	0.000174	0.000238	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000174	0.000934	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CRABP1—kidney cancer	0.000173	0.000927	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000168	0.000903	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Doxorubicin—kidney cancer	0.000168	0.000229	CcSEcCtD
Fluocinolone Acetonide—Rash—Doxorubicin—kidney cancer	0.000166	0.000227	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Doxorubicin—kidney cancer	0.000166	0.000227	CcSEcCtD
Fluocinolone Acetonide—Headache—Doxorubicin—kidney cancer	0.000165	0.000225	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPL14—kidney cancer	0.000162	0.000867	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ITPR2—kidney cancer	0.000161	0.000862	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKAP13—kidney cancer	0.000158	0.000848	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP2—kidney cancer	0.000158	0.000848	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Doxorubicin—kidney cancer	0.000157	0.000214	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	0.000155	0.000831	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000148	0.000795	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTT1—kidney cancer	0.000147	0.000786	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ACHE—kidney cancer	0.000147	0.000786	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRB7—kidney cancer	0.000145	0.000775	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SCARB1—kidney cancer	0.000139	0.000744	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS1—kidney cancer	0.000137	0.000737	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PSMD7—kidney cancer	0.000135	0.000722	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ITPR2—kidney cancer	0.000134	0.000721	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—RAF1—kidney cancer	0.000134	0.00072	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	0.000132	0.000707	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HSPB1—kidney cancer	0.000132	0.000707	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—BCHE—kidney cancer	0.000128	0.000685	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC5A5—kidney cancer	0.000126	0.000676	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PSMD7—kidney cancer	0.000123	0.000657	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CTNNA1—kidney cancer	0.000122	0.000653	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC2A1—kidney cancer	0.000122	0.000653	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EIF4EBP1—kidney cancer	0.000121	0.00065	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HSPB1—kidney cancer	0.000121	0.00065	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IL2—kidney cancer	0.00012	0.000645	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000118	0.000634	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PSMD7—kidney cancer	0.000113	0.000604	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TSC1—kidney cancer	0.000113	0.000604	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ANXA1—kidney cancer	0.000113	0.000604	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—JUNB—kidney cancer	0.00011	0.00059	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FLT1—kidney cancer	0.000109	0.000585	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000103	0.000553	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—kidney cancer	0.000102	0.000548	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTP1—kidney cancer	0.000102	0.000545	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PAK1—kidney cancer	0.000101	0.000542	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JUNB—kidney cancer	0.000101	0.000542	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK3—kidney cancer	9.67e-05	0.000519	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCB1—kidney cancer	9.61e-05	0.000516	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—POMC—kidney cancer	9.34e-05	0.000501	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—kidney cancer	9.33e-05	0.000501	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK1—kidney cancer	9.2e-05	0.000494	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CDKN2B—kidney cancer	8.95e-05	0.00048	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1A1—kidney cancer	8.85e-05	0.000475	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KRAS—kidney cancer	8.69e-05	0.000466	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF2—kidney cancer	8.26e-05	0.000443	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN2B—kidney cancer	8.23e-05	0.000441	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1R—kidney cancer	7.99e-05	0.000429	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—kidney cancer	7.98e-05	0.000428	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—kidney cancer	7.72e-05	0.000414	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RAF1—kidney cancer	7.7e-05	0.000413	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.27e-05	0.00039	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	7.21e-05	0.000387	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL2—kidney cancer	6.9e-05	0.00037	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—POMC—kidney cancer	6.6e-05	0.000354	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIF1A—kidney cancer	6.58e-05	0.000353	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TSC2—kidney cancer	6.56e-05	0.000352	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KDR—kidney cancer	6.29e-05	0.000337	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KIT—kidney cancer	5.8e-05	0.000311	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APC—kidney cancer	5.8e-05	0.000311	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK3—kidney cancer	5.55e-05	0.000298	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—POMC—kidney cancer	5.52e-05	0.000296	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BRAF—kidney cancer	5.45e-05	0.000292	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK1—kidney cancer	5.28e-05	0.000283	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—kidney cancer	5.26e-05	0.000282	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KRAS—kidney cancer	4.99e-05	0.000268	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTEN—kidney cancer	4.59e-05	0.000246	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—kidney cancer	4.58e-05	0.000246	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RAF1—kidney cancer	4.55e-05	0.000244	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RELA—kidney cancer	4.53e-05	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB2—kidney cancer	4.5e-05	0.000241	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MTOR—kidney cancer	4.44e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1B—kidney cancer	4.17e-05	0.000224	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL2—kidney cancer	4.08e-05	0.000219	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCND1—kidney cancer	3.98e-05	0.000213	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JUN—kidney cancer	3.97e-05	0.000213	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CTNNB1—kidney cancer	3.94e-05	0.000211	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTEN—kidney cancer	3.84e-05	0.000206	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MAPK3—kidney cancer	3.57e-05	0.000191	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MYC—kidney cancer	3.47e-05	0.000186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—kidney cancer	3.47e-05	0.000186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK3—kidney cancer	3.28e-05	0.000176	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—kidney cancer	3.24e-05	0.000174	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MYC—kidney cancer	3.19e-05	0.000171	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK1—kidney cancer	3.12e-05	0.000167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KRAS—kidney cancer	2.95e-05	0.000158	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—kidney cancer	2.71e-05	0.000145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—kidney cancer	2.62e-05	0.00014	CbGpPWpGaD
